SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000891618-02-002553
Filing Date
2002-05-22
Accepted
2002-05-22 16:02:53
Documents
1
Period of Report
2002-04-29
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K f81946a1e8-ka.htm 8-K/A 49733
  Complete submission text file 0000891618-02-002553.txt   51314
Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-22570 | Film No.: 02659921
SIC: 2833 Medicinal Chemicals & Botanical Products